Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00971568 · ClinicalTrials.gov registry record
Urinary Biomarkers Characteristic to Interstitial Cystitis
A clinical trial of Interstitial Cystitis, sponsored by Corewell Health East.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT00971568: Completed study of Interstitial Cystitis, sponsored by Corewell Health East.
NCT00971568 is a study of Interstitial Cystitis that has completed, run by Corewell Health East. The registered enrollment target is 15 participants, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00971568, a study of Interstitial Cystitis, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective study of urine samples stored in the Beaumont BioBank for future research. The urine samples will be drawn from the urine back with patients previously diagnosed with severe interstitial cystitis (IC), mild IC and no IC. Interstitial Cystitis (IC) also known as Painful Bladder Syndrome (PBS) is a chronic inflammatory disease. It has an unknown etiology, symptoms which present to varying degrees, as well as an uncertain natural history. Diagnosis of IC is based on symptoms after excluding more common and dangerous pathologies.
Conditions Studied
Study Locations (1)
Michigan
- Beaumont Hospitals-Royal Oak - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-09 |
What the finished NCT00971568 record still lists
NCT00971568 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Interstitial Cystitis appearing as the primary indexed condition, and to 0 interventions.
NCT00971568 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00971568 about?
NCT00971568 is a clinical study titled "Urinary Biomarkers Characteristic to Interstitial Cystitis". This is a retrospective study of urine samples stored in the Beaumont BioBank for future research. The urine samples will be drawn from the urine back with patients previously diagnosed with severe interstitial cystitis (IC), mild IC and no IC. Interstitial Cystitis (IC) also known as Painful Bladd...
What is the current status of trial NCT00971568?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2009-09. Estimated completion is 2011-09.
What conditions does trial NCT00971568 study?
This clinical trial studies the following conditions: Interstitial Cystitis.
Who is sponsoring clinical trial NCT00971568?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00971568 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00971568's enrollment target sits among peer trials
15 23rd of 26 higher than 4 of 26 other Interstitial Cystitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Interstitial Cystitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
RECRUITING · Phase 1
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
RECRUITING · NA
-
Identifying Genetic Causes of IC/BPS
RECRUITING
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
-
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia